What Researchers Did
Researchers conducted a review to outline the importance of oxygen to tumors, mechanisms of tumor survival under hypoxic conditions, and the effects of hyperbaric oxygen therapy on malignancy based on experimental and clinical data.
What They Found
The review found that hypoxic tumor regions are relatively insensitive to conventional therapy, and hyperbaric oxygen (HBO) therapy can increase tumor oxygen tensions. Data from both experimental and clinical studies suggest HBO influences the tumor microenvironment by altering hypoxia and producing reactive oxygen species, potentially damaging tumors and improving treatment outcomes.
What This Means for Canadian Patients
For Canadian patients, this review suggests that hyperbaric oxygen therapy could potentially enhance the effectiveness of conventional cancer treatments by addressing tumor hypoxia. However, further research and clinical trials are necessary to establish its definitive role and practical application in cancer care.
Canadian Relevance
This review has no specific Canadian connection, as it does not involve Canadian researchers, institutions, or patient populations.
Study Limitations
As a review, this study synthesizes existing data and does not present new primary research or clinical trial results, thus reflecting the limitations of the included studies.